Epstein Secrets

transaction for tax purposes; • a United States holder (as defined below) whose functional currency for tax purposes is not the U.S. dollar; • a United State expatriate; or • a person liable for alternative minimum tax. This section is based on the United States Internal Revenue Code of 1986. as amended

agency or instrumentality of the United States, including the FRB and other federal bank regulatory agencies) or any political subdivision of or in the United States that is enacted or becomes effective after the initial issuance of any share of the Series F Preferred Stock, (ii) any proposed change in those laws

erson and you have furnished a valid IRS Form W-8 or other documentation upon which the payor or broker may rely to treat the payments as made to a non-United States person, or (ii) you othenvise establish an exemption. Payment of the proceeds from the sale of Series F Preferred Stock effected at a foreign office

e stockholder vote. The Lead Director will then refer the matter to the Corporate Governance and Nominating Committee. The Corporate Governance and Nominating Committee will promptly consider the resignation submitted by such director and will recommend to the full Board whether to accept such resignation. The Corpo

T, Rich W, Hall RCW: Investigating the Factors Influencing the 21 EFTA00073138 Prescription of Antidepressants with No FDA-Approved Indication in the United States Between 2006 — 2009. - Annual Meeting, American College of Clinical Pharmacy, Hollywood, FL, Oct 22, 2012. 6. Marriner B, Rich W, Matthews A, Hall

9 Ethics Committee, Florida Psychiatric Society 2010 - 2011 Member, New Member Task Force, Southern Psychiatric Association 2010 - 2011 Member, Nominating Committee, Seminole County Medical Society 2011 Chairman, AMA-YPS Handbook Review Committee, AMA Interim Meeting, New Orleans, LA, November 2012 - 2020 M

T, Rich W, Hall RCW: Investigating the Factors Influencing the 21 EFTA00090166 Prescription of Antidepressants with No FDA-Approved Indication in the United States Between 2006 — 2009. - Annual Meeting, American College of Clinical Pharmacy, Hollywood, FL, Oct 22, 2012. 6. Marriner B, Rich W, Matthews A, Hall

9 Ethics Committee, Florida Psychiatric Society 2010 - 2011 Member, New Member Task Force, Southern Psychiatric Association 2010 - 2011 Member, Nominating Committee, Seminole County Medical Society 2011 Chairman, AMA-YPS Handbook Review Committee, AMA Interim Meeting, New Orleans, LA, November 2012 - 2020 M

Distinguished Life Fellow, 2007-present Consultant, Task Force on the Right to Treatment, 1974-1977 Committee on Misuse and Abuse of Psychiatry in the United States, 1979-1980 Committee on Abuse and Misuse of Psychiatry and Psychiatrists in the United States, 1980-1987 (Chairman, 1984-1986) Advisory Committee

ms) Fellow-at-Large, Psychiatry Section, 1982-1985 Executive Committee, 1982-1985 Annual Meeting Program Committee, 1979-1981 Council, 1979-1982 Nominating Committee, 1979-1982 Membership Committee, 1979-1982 Joint Committee on Accreditation of Training Programs in Forensic Psychiatry, 1980-1986 American Acade